Real World Evidence in the COVID Era: Pfizer’s vaccine approval for children
VirtualJoin the NC TraCS Comparative Effectiveness Research team and guest expert Cindy Gay, MD, MPH, to review and discuss the now available data on the safety and effectiveness of the Pfizer vaccine in children ages 5 - 11.
Reference materials for this discussion:
Pfizer briefing document for Advisory Committee meeting: https://www.fda.gov/media/153409/download
FDA benefit and risk analysis: https://www.fda.gov/media/153447/download